Your browser doesn't support javascript.
loading
PANSS Individual Item and Marder Dimension Analyses From a Pivotal Trial of RBP-7000 (Monthly Extended-Release Risperidone) in Schizophrenia Patients.
Le Moigne, Anne; Csernansky, John; Leadbetter, Robert A; Andorn, Anne C; Graham, James A; Heath, Amy T; Walling, David P; Newcomer, John W; Marder, Stephen R.
Afiliação
  • Le Moigne A; Global Research & Development, Indivior Inc., North Chesterfield, Virginia.
  • Csernansky J; Corresponding author: Anne Le Moigne, MD, Clinical/Data Sciences and Operations, Indivior Inc., 10710 Midlothian Turnpike, Ste 125, North Chesterfield, VA 23235 (anne.le.moigne@indivior.com).
  • Leadbetter RA; Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Andorn AC; Global Research & Development, Indivior Inc., North Chesterfield, Virginia.
  • Graham JA; Global Research & Development, Indivior Inc., North Chesterfield, Virginia.
  • Heath AT; Global Research & Development, Indivior Inc., North Chesterfield, Virginia.
  • Walling DP; Global Research & Development, Indivior Inc., North Chesterfield, Virginia.
  • Newcomer JW; Collaborative Neuroscience Network LLC, Garden Grove, California.
  • Marder SR; Washington University School of Medicine, St Louis, Missouri, and Thriving Mind South Florida, Miami, Florida.
J Clin Psychiatry ; 82(5)2021 09 21.
Article em En | MEDLINE | ID: mdl-34551218

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escalas de Graduação Psiquiátrica / Esquizofrenia / Antipsicóticos / Risperidona Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escalas de Graduação Psiquiátrica / Esquizofrenia / Antipsicóticos / Risperidona Idioma: En Ano de publicação: 2021 Tipo de documento: Article